International Immunology Advance Access originally published online on December 21, 2007
International Immunology 2008 20(2):209-214; doi:10.1093/intimm/dxm135
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential roles for IFN-
and IL-17 in experimental autoimmune uveoretinitis
1 Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka
2 Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka
3 Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga
4 Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
Correspondence to: H. Yoshida; E-mail: yoshidah{at}med.saga-u.ac.jp
IL-17-producing CD4+ T cells, so called Th17 cells, constitute a newly identified inflammatogenic cell population, which is critically involved in some inflammatory diseases. To explore the role of Th17 cells in murine experimental autoimmune uveoretinitis (EAU), a model of human autoimmune uveitis where Th1 responses predominantly participate in the pathogenesis, IL-17–/– mice were immunized with interphotoreceptor retinoid-binding protein peptide 1–20 for disease induction. Funduscopic examination revealed that EAU was induced in IL-17–/– mice just like in wild-type (WT) mice at early phases of the disease. However, at later/maintenance phases, the severity was significantly reduced in IL-17–/– mice. Expression of IFN-
and MCP-1 was comparable between WT and IL-17–/– mice during the time course. In vivo blockade of IFN-
and IL-4 resulted in exacerbation of EAU at later phases with augmented IL-17 production. Taken together, our data demonstrated that IL-17/Th17 participates in the late phases of EAU and also that Th1 and Th17 responses are differentially required for EAU.
Keywords: autoimmunity, cytokines, inflammation, Th1, Th17
Transmitting editor: T. Watanabe
Received 27 April 2007, accepted 22 November 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. D. Doodes, Y. Cao, K. M. Hamel, Y. Wang, B. Farkas, Y. Iwakura, and A. Finnegan Development of Proteoglycan-Induced Arthritis Is Independent of IL-17 J. Immunol., July 1, 2008; 181(1): 329 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Cox, G. Shi, H. Yin, B. P. Vistica, E. F. Wawrousek, C.-C. Chan, and I. Gery Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities J. Immunol., June 1, 2008; 180(11): 7414 - 7422. [Abstract] [Full Text] [PDF] |
||||
